Henry Schein (HSIC) Competitors $67.65 -0.19 (-0.29%) As of 02:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HSIC vs. COO, IDXX, MASI, MMSI, AMN, AVNS, BRBR, NVST, WST, and OMIShould you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Masimo (MASI), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), AVANOS MEDICAL (AVNS), BellRing Brands (BRBR), Envista (NVST), West Pharmaceutical Services (WST), and Owens & Minor (OMI). Henry Schein vs. Its Competitors Cooper Companies IDEXX Laboratories Masimo Merit Medical Systems AMN Healthcare Services AVANOS MEDICAL BellRing Brands Envista West Pharmaceutical Services Owens & Minor Henry Schein (NASDAQ:HSIC) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings. Which has stronger earnings and valuation, HSIC or COO? Cooper Companies has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHenry Schein$12.67B0.65$390M$3.1021.82Cooper Companies$3.90B3.80$392.30M$2.0635.96 Which has more volatility and risk, HSIC or COO? Henry Schein has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500. Is HSIC or COO more profitable? Cooper Companies has a net margin of 10.39% compared to Henry Schein's net margin of 3.05%. Henry Schein's return on equity of 14.36% beat Cooper Companies' return on equity.Company Net Margins Return on Equity Return on Assets Henry Schein3.05% 14.36% 5.52% Cooper Companies 10.39%9.60%6.35% Does the media refer more to HSIC or COO? In the previous week, Cooper Companies had 1 more articles in the media than Henry Schein. MarketBeat recorded 24 mentions for Cooper Companies and 23 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.45 beat Cooper Companies' score of 1.03 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 17 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cooper Companies 16 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts rate HSIC or COO? Henry Schein currently has a consensus price target of $75.58, indicating a potential upside of 11.73%. Cooper Companies has a consensus price target of $96.73, indicating a potential upside of 30.59%. Given Cooper Companies' stronger consensus rating and higher probable upside, analysts clearly believe Cooper Companies is more favorable than Henry Schein.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 0 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.33Cooper Companies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.92 Do institutionals & insiders believe in HSIC or COO? 96.6% of Henry Schein shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 1.1% of Henry Schein shares are held by company insiders. Comparatively, 2.0% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryCooper Companies beats Henry Schein on 12 of the 17 factors compared between the two stocks. Get Henry Schein News Delivered to You Automatically Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSIC vs. The Competition Export to ExcelMetricHenry ScheinMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.20B$15.06B$5.72B$9.77BDividend YieldN/A1.50%3.77%4.10%P/E Ratio21.8218.0230.9025.26Price / Sales0.652.46403.8188.28Price / Cash9.2516.5425.2228.45Price / Book2.093.789.516.00Net Income$390M$472.13M$3.26B$265.34M7 Day Performance2.34%2.70%4.48%2.84%1 Month Performance-2.10%4.26%5.19%1.58%1 Year Performance-3.07%13.82%31.75%25.40% Henry Schein Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSICHenry Schein4.1892 of 5 stars$67.65-0.3%$75.58+11.7%-2.8%$8.20B$12.67B21.8225,000Positive NewsCOOCooper Companies3.9994 of 5 stars$70.88+0.8%$96.73+36.5%-22.2%$14.17B$3.90B34.4116,000Positive NewsIDXXIDEXX Laboratories4.3353 of 5 stars$652.11-0.9%$644.67-1.1%+32.2%$52.17B$4.04B54.3011,000Positive NewsAnalyst ForecastAnalyst RevisionMASIMasimo4.4642 of 5 stars$147.37+1.8%$193.60+31.4%+24.7%$8.01B$2.15B-17.305,600MMSIMerit Medical Systems4.5032 of 5 stars$84.04-1.8%$107.00+27.3%-5.9%$4.98B$1.36B42.667,400AMNAMN Healthcare Services4.3372 of 5 stars$16.46-4.6%$30.25+83.8%-63.7%$629.98M$2.85B-2.122,968AVNSAVANOS MEDICAL3.0697 of 5 stars$10.52-2.8%N/A-52.1%$488.17M$687.80M-1.042,227Insider TradeShort Interest ↑BRBRBellRing Brands4.3032 of 5 stars$38.86-0.3%$67.86+74.6%-30.1%$4.94B$2.00B22.21380Analyst ForecastInsider TradeNVSTEnvista3.535 of 5 stars$20.19-0.3%$20.92+3.7%+15.4%$3.35B$2.51B63.0812,300WSTWest Pharmaceutical Services4.6949 of 5 stars$240.40-0.2%$320.71+33.4%-18.1%$17.29B$2.96B35.9910,600Positive NewsAnalyst RevisionOMIOwens & Minor4.8226 of 5 stars$4.65-34.5%$11.60+149.7%-64.5%$358.83M$10.70B-0.9823,200Earnings ReportHigh Trading Volume Related Companies and Tools Related Companies COO Competitors IDXX Competitors MASI Competitors MMSI Competitors AMN Competitors AVNS Competitors BRBR Competitors NVST Competitors WST Competitors OMI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSIC) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Henry Schein, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Henry Schein With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.